Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2007 Jul 5;25(Suppl 2):22–25. doi: 10.1002/clc.4960251407

Treatment options for angina pectoris and the future role of enhanced external counterpulsation

David R Holmes Jr 1,
PMCID: PMC6654331  PMID: 12489600

Abstract

Patients with coronary artery disease have a variety of treatment options available to them. These include medications to control anginal episodes and, when appropriate, revascularization interventions in the form of coronary artery bypass graft and angioplasty. Despite advances in the treatment of angina, a substantial number of patients continue to have symptoms that can significantly impair their quality of life. These patients may benefit from enhanced external counterpulsation (EECP). With recent results of the latest clinical trial of EECP just published, the role of EECP, including its position in the hierarchy of treatment options, needs to be seriously considered.

Keywords: angina pectoris, angioplasty, coronary artery bypass graft, coronary artery disease, enhanced external counterpulsation

Full Text

The Full Text of this article is available as a PDF (149.6 KB).

References

  • 1. Stys TP, Lawson WE, Hui JC, Fleishman B, Manzo K, Strobeck JE, Tartaglia J, Ramasamy S, Suwita R, Zheng ZS, Liang H, Werner D: Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol 2002; 89: 822–824 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES